Back
Genmab A/S 10K Form
Sell
33
GNMSF
Genmab A/S
Last Price:
$265.00
Seasonality Move:
3.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNMSF News And Ratings
See the #1 stock for the next 7 days that we like better than GNMSF
GNMSF Financial Statistics
Sales & Book Value
| Annual Sales: | $3.7B |
|---|---|
| Cash Flow: | $284M |
| Price / Cash Flow: | 14.48 |
| Annual Sales: | $94.89 |
| Price / Book: | 2.79 |
Profitability
| EPS (TTM): | 15.43410 |
|---|---|
| Net Income (TTM): | $963M |
| Gross Margin: | $3.4B |
| Return on Equity: | 17.64% |
| Return on Assets: | 12.25% |
Genmab A/S Earnings Forecast
Key Genmab A/S Financial Ratios
-
The Gross Profit Margin over the past 19 years for GNMSF is 91.69%.
-
The Selling, General & Administrative Expenses for GNMSF have been equal to 16.83% of Gross Profit Margin.
-
The Research & Development expenses have been 41.91% of Revenue.
-
The Interest Expense is 6.33% of Operating Income.
-
The Net Earning history of GNMSF is 25.89% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 16 years.
Genmab A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNMSF |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0.93 |
|---|---|
| Current Ratio: | 2.02 |
| Quick Ratio: | 1.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.25 |
|---|---|
| Forward P/E Ratio: | 0 |
GNMSF Technical Analysis vs Fundamental Analysis
Sell
33
Genmab A/S (GNMSF)
is a Sell
Is Genmab A/S a Buy or a Sell?
-
Genmab A/S stock is rated a SellThe current Genmab A/S [GNMSF] share price is $265.00. The Score for GNMSF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.